摘要
特发性局灶节段性肾小球硬化（FSGS）是原发性肾小球疾病中常见的病理类型之一，主要临床表现为不同程度蛋白尿，其中909／6的儿童和70％的成人患者表现为肾病性蛋白尿，30％～45％的患者可发生高血压。FSGS自然病程短，预后较差，在发病5～10年后约20％～30％的患者可进入终末期肾脏病（ESRD）。目前认为特发性FSGS进展为ESRD的主要因素：大量蛋白尿、高血压、
出处
《临床肾脏病杂志》
2009年第6期249-251,共3页
Journal Of Clinical Nephrology
参考文献15
-
1Nagai R, Cattran DC, Pei Y. Steroid therapy and prognosis of focal segmental glomerulosclerosis in the elderly. Clin Nephrol, 1994,42:18-21.
-
2Mori K, Honda M, Ikeda M. Efficacy of methylprednisolone pulse therapy in steroid resistant nephrotic syndrome. Pediatr Nephrol, 2004,19:1232 1236.
-
3Mendoza SA, Tune BM. Management of the difficult nephrotie patient. Pediatr Clin North Am, 1995,42:1459-1468.
-
4Ehrich JHH, Pape L, Schiffer M. Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis. Pediatr Drugs, 2008,10 : 9-22.
-
5Abeyagunawardena AS, Sebire N J, Risdon RA, et al. Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis. Pediatr Nephrol, 2007,22 : 215-221.
-
6Alshaya H, AI Maghrabi JA, Kari JA. Intravenous pulse eyclophosphamide: Is it effective with steroid-resistant nephrotie syndrome? Pediat r Nephrol, 2003,18 : 1143-1146.
-
7Habashy D, Hodson EM, Craig JC. Interventions for steroid-resistant nephrotie syndrome: A systematic review. Pediatr Nephrol, 2003,18 : 906 912.
-
8Meyrier A. Treatment of idiopathic nephrosis by immunophillin modulation. Nephrol Dial Transplant, 2003,18 : 79-86.
-
9Cattran DC,Appel GB, Herbert L,et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int, 1999,56 : 2220-2226.
-
10Banff G, Moriggi M, Sabadini E, et al. The impact of prolonged immunosuppression on the outcome of idiopathic focal segmental glomerulosclerosis in adults. Clin Nephrol, 1991,36:53-59.
同被引文献13
-
1刘东,马俊杰,桂泽红,陈忠华,郑克立.血浆置换治疗移植肾复发性FSGS合并大量蛋白尿的远期观察[J].中华器官移植杂志,2006,27(3):170-172. 被引量：3
-
2杨林,彭爱民,夏进标,张祥文,钟文旗.贝那普利治疗局灶节段性肾小球硬化症的疗效[J].中国药师,2006,9(9):812-814. 被引量：2
-
3Daskalakis N, Winn MP. Focal and segmental glomerulosclerosis: Varying biologic mechanisms underlie a final histopathologic end point. Semin Nephrol, 2006,26 : 89-94.
-
4Deegens JKJ, Steenbergen EJ, Wetzels JFM. Review on diagnosis and treatment of focal segmental g[omerulosclerosis. Neth J Med, 2008,66:3- 12.
-
5郑继光.局灶节段性肾小球硬化.见:谢佩法,陈严文,李正良,主编.实用肾脏病治疗学.吉林:吉林科学技术出版社,2005.129.
-
6Cattran DC,Wang MM, Appel G, et al. Mycophenolate mofetilin the treatment of focal segmental glomerulosclerosis. Clin Nephrol, 2004,62:405-411.
-
7Ito S, Maehida H, Inaba A, et al. Amelioration of steroids and cyclosporine resistant nephritic syndrome by pravastatin. Pediatr Nephrol, 2007,22 : 603 -606.
-
8Loeffler K,Gowrishankar M, Yiu V. Tacrolimus therapy in pediatric paients with treatment resistant nephrotic syndrome. Pediatr Nephrol,2004,19 : 281- 287.
-
9Tumlin JA, Miller D, Near M, et al. A prospective,open-label trial of sirolimus in the treatment of focal segmental glomeruloselerosis. Clin J Am Soc Nephrol,2006,1 : 109-116.
-
10Goumenos DS, Tsagalis G, El Nahas AM, et al. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: A five-year follow up study. Nephron Clin Praet, 2006,104: 75-82.
-
1戎殳,姚小丹.特发性局灶节段性肾小球硬化患者的发生都一样吗?[J].肾脏病与透析肾移植杂志,1998,7(5):503-504.
-
2汪昌雄,郑启刚,刘维丽,夏芳.他克莫司对特发性局灶节段性肾小球硬化的疗效观察[J].中国医师进修杂志,2013,36(25):50-51. 被引量：3
-
3V K K Tam.蛋白尿[J].全科医学杂志,2001,6(3):190-192.
-
4孟雷,胡淑荣,方佛友.“慢肾丸”治疗肾病性蛋白尿32例[J].安徽中医临床杂志,1994,6(3):6-6.
-
5伍秋霞,刘芸芳,彭小梅,雷丽丽.正清风痛宁治疗特发性局灶节段性肾小球硬化[J].现代中西医结合杂志,2009,18(21):2496-2498. 被引量：2
-
6姚刚,姚小丹南京军区南京总医院解放军肾脏病研究所.特发性局灶节段性肾小球硬化的治疗[J].肾脏病与透析肾移植杂志,2000,9(5):463-466. 被引量：1
-
7曹雪莹.膜性肾病的治疗策略[J].中国医刊,2008,43(3):20-21. 被引量：2
-
8关天俊,刘志红.特发性局灶节段性肾小球硬化发病机理中循环因子的研究[J].肾脏病与透析肾移植杂志,1996,5(5):54-56.
-
9张敬京,杨霁云.局灶节段性肾小球硬化的研究进展[J].中华儿科杂志,1998,36(4):253-255. 被引量：3
-
10李新东,荆淑芳.非典型肾小球肾炎临床与病理相关性探讨[J].海南医学,1999,10(6):187-188.
